Respiratory Tract Infections Drug Development Pipeline Review, 2018; New Report Launched
Respiratory Tract Infections Drug Development Pipeline Review, 2018 report provides an overview of the pipeline landscape for respiratory tract infections. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for tuberculosis, diphtheria and pertussis (whooping cough), and features dormant and discontinued products.
View full press release